Detalles de la búsqueda
1.
Clinical and economic burden of pneumococcal disease among individuals aged 16 years and older in Germany.
Epidemiol Infect
; 150: e204, 2022 11 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36345842
2.
Pneumococcal vaccination coverage in individuals (16-59 years) with a newly diagnosed risk condition in Germany.
BMC Infect Dis
; 22(1): 753, 2022 Sep 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36171549
3.
Adherence to hepatitis A and hepatitis B multi-dose vaccination schedules among adults in the United Kingdom: a retrospective cohort study.
BMC Public Health
; 19(1): 404, 2019 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30987613
4.
A cross-sectional survey of work and income loss consideration among patients with herpes zoster when completing a quality of life questionnaire.
BMC Health Serv Res
; 18(1): 662, 2018 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-30144806
5.
Association between work time loss and quality of life in patients with Herpes Zoster: a pooled analysis of the MASTER studies.
Health Qual Life Outcomes
; 15(1): 11, 2017 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-28100258
6.
Longitudinal association between BMI at diagnosis and HIV disease progression.
AIDS Behav
; 18(11): 2249-57, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24880700
7.
Lifetime Health and Economic Burden of Invasive Pneumococcal Diseases Attributable to V116 Serotypes Among Adults in the United States.
Infect Dis Ther
; 13(7): 1501-1514, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38796565
8.
Qualification of a 21-valent pneumococcal urine antigen detection assay and development of clinical positivity cutoffs.
Bioanalysis
; : 1-12, 2024 Jun 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38940371
9.
Pneumococcal vaccination coverage among US adults enrolled in Medicaid and newly diagnosed with underlying medical conditions.
Expert Rev Vaccines
; 22(1): 596-607, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37401893
10.
Regional factors associated with pneumococcal vaccination coverage among U.S. adults with underlying chronic or immunocompromising conditions.
Hum Vaccin Immunother
; 19(1): 2194779, 2023 12 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37038308
11.
Cost-Effectiveness of Pneumococcal Vaccination in Adults in Italy: Comparing New Alternatives and Exploring the Role of GMT Ratios in Informing Vaccine Effectiveness.
Vaccines (Basel)
; 11(7)2023 Jul 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37515068
12.
Clinical and economic burden of pneumococcal disease among adults in Sweden: A population-based register study.
PLoS One
; 18(7): e0287581, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37418396
13.
Estimates of the Health and Economic Burden of Pneumococcal Infections Attributable to the 15-Valent Pneumococcal Conjugate Vaccine Serotypes in the USA.
Infect Dis Ther
; 11(3): 987-999, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35084647
14.
Pneumococcal vaccination coverage among adults newly diagnosed with underlying medical conditions and regional variation in the U.S.
Vaccine
; 40(33): 4856-4863, 2022 08 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35803847
15.
Cost and health impact analysis of herpes zoster vaccination in Norway.
Expert Rev Pharmacoecon Outcomes Res
; 22(2): 315-326, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34488508
16.
A Multicenter Evaluation of Trends in Antimicrobial Resistance Among Streptococcus pneumoniae Isolates From Adults in the United States.
Open Forum Infect Dis
; 9(9): ofac420, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-36168549
17.
Cost-effectiveness of the 15-valent pneumococcal conjugate vaccine for high-risk adults in Switzerland.
Expert Rev Vaccines
; 21(5): 711-722, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35220875
18.
Pneumococcal vaccination coverage among adults aged 19 to 64 years with immuno-compromising conditions, cerebrospinal fluid (CSF) leaks, or cochlear implants in the US.
Expert Rev Vaccines
; 20(3): 331-345, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33724134
19.
Efficacy and effectiveness of a 23-valent polysaccharide vaccine against invasive and noninvasive pneumococcal disease and related outcomes: a review of available evidence.
Expert Rev Vaccines
; 20(3): 243-256, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33478306
20.
Results from a cross-sectional, observational study to assess inadequate pain relief in patients with knee and/or hip osteoarthritis in Mexico.
Reumatol Clin (Engl Ed)
; 17(7): 397-403, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34301383